Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block for Wound Healing in C-Section
NCT05840406Completed
- Sponsor
- University Hospital Center Sestre milosrdnice
- Start
- Sep 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of levobupivacaine and dexmedetomidine in postoperative pain (3 arms), sponsored by University Hospital Center Sestre milosrdnice. Primary endpoints: Wound healing (REEDA scale) at 72 hours, Serum cortisol levels at 72 hours and 2 more. Started Sep 2024; status: completed.
02
Drugs
levobupivacainedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05840406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05840406.